INVEX Therapeutics Ltd (ixc) Logo

INVEX Therapeutics Ltd (IXC)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE

IXC ASX Chart

Snapshot

Invex Therapeutics Ltd (ASX: IXC) is a clinical-stage biopharmaceutical company focused on the development and commercialisation of Presendin (sustained release Exenatide) for neurological conditions relating to raised intracranial pressure.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2024 YTD
1 Year
vs Sector (1yr) -84.73%
vs ASX 200 (1yr) -93.12%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 1,985 of 2,380
Sector Rank 192 of 223

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies JHL / ANR / MEB
EPS -$0.08
DPS $0.00
Book Value Per Share $0.283

Broker Consensus

Please see the Broker Consensus page.

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Subiaco WA 6008
Website www.invextherapeutics.com
Registry Automic Group
Auditor BDO (Audit) WA Pty Ltd
Date Listed 5 Jul 2019

Upcoming Calendar (Forecasted)

Date Event
15/08/2024 Report (Prelim)
15/08/2024 Report (Annual)
14/02/2025 Report (Interim)

Former Company Names

  • INVEX Therapeutics Ltd has no former company names.

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Transactions

IXC directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
10/11/23 Megan Baldwin Cancelled 100,000 $0.225 $22,500 As advised by the company
24/08/23 Thomas (Tom) Duthy Buy +178,738 $0.180 $32,172 On-market trade
01/12/22 Megan Baldwin Issued 200,000 $0.580 $116,000 Issue of options
01/12/22 Thomas (Tom) Duthy Issued 1,000,000 $0.580 $580,000 Issue of options
01/12/22 Jason Loveridge Issued 1,280,000 $0.580 $742,400 Issue of options
01/12/22 Alexandra Sinclair Issued 1,120,000 $0.580 $649,600 Issue of options
08/04/21 Megan Baldwin Issued 400,000 $0.775 $310,000 Issue of options
18/11/20 Thomas (Tom) Duthy Issued 800,000 $0.805 $644,000 Issue of options
22/11/19 Alexandra Sinclair Issued 800,000 $0.710 $568,000 Issue of options
22/11/19 David McAuliffe Issued 200,000 $0.710 $142,000 Issue of options
22/11/19 Jason Loveridge Issued 800,000 $0.710 $568,000 Issue of options
22/11/19 Narelle Warren Issued 400,000 $0.710 $284,000 Issue of options

Director Interests

The current holdings of IXC directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Thomas (Tom) Duthy 18/11/2023 N/A 285,661 500,000 N/A
Megan Baldwin 10/11/2023 0 N/A 500,000 N/A
David Wheeler 08/11/2023 0 N/A N/A N/A
David McAuliffe 30/06/2023 3,350,001 N/A 200,000 N/A
Narelle Warren 01/10/2020 N/A 200,000 400,000 N/A

Shareholder Info

Top 20 Shareholders

Data supplied by Morningstar and accurate on Aug 1, 2023.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Tattarang 8,846,154 11.77%
Tisia Nominees Pty Ltd <Henderson Family A/C> 3,725,000 4.96%
Mr Jason Loveridge 3,374,462 4.49%
Mr David Jerimiah Mcauliffe 3,350,001 4.46%
Jk Nominees Pty Ltd <The Jk Fund A/C> 3,000,000 3.99%
Prof Alexandra Jean Sinclair 2,500,000 3.33%
Mrs Kathryn Salkilld 2,293,000 3.05%
The University Of Birmingham 2,000,000 2.66%
Bannaby Investments Pty Limited<Bannaby Super Fund A/C> 1,625,000 2.16%
Sunset Capital Management Pty Ltd<Sunset Superfund A/C> 1,448,175 1.93%
Anthony Grist 1,338,518 1.78%
Cityscape Asset Pty Ltd<Cityscape Family A/C> 1,150,000 1.53%
Cabletime Pty Ltd <Ingodwe A/C> 1,120,000 1.49%
Sandhurst Trustees Ltd<Collins St Value Fund A/C> 1,081,924 1.44%
Palla Nominees Pty Ltd <P C Blackman S/F No 2 A/C> 580,000 0.77%
Ardroy Securities Pty Ltd<Cameron Investment Unit A/C> 550,407 0.72%
Endless Summer (Wa) Pty Ltd<Peter Nelson Super Fund A/C> 550,000 0.73%
Ms Sophie Alice Loveridge 493,000 0.66%
Peter Kyros Pty Ltd <Kyros Sf A/C> 470,075 0.63%
Webinvest Pty Ltd<Olsb Unit A/C> 375,000 0.50%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 208 478 237 461 101 1,485

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.

Name Last Notice Total Shares Shares Held (%)
Tattarang Pty Ltd 01/08/2023 8,846,154 11.77
Mr Jason Peterson 07/11/2023 7,705,675 10.25

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
07-11-23 Mr Jason Peterson 2,912,792 6.38 10.25
04-11-23 Mr Jason Peterson 1,101,825 10.25 11.72
28-09-23 Mr Jason Peterson 797,807 5.32 6.38
31-08-23 Mr Jason Peterson 3,995,076 -- 5.32

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2023 $0.200 30 June
2022 $0.495 30 June
2021 $0.630 30 June
2020 $1.30 30 June
IXC Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.